Theoretical and applied methods of safeguarding future fertility in patients undergoing high-dose cytotoxic treatment.
| Procedure . | Male . | Female . |
|---|---|---|
| Ligand-receptor mediated | GnRHa | GnRHa, steroids |
| Inhibition of apoptosis | - | Bax |
| Surgical | - | Ovarian transposition |
| Cryopreservation | Sperm, spermatogonia | Embryos, oocytes, primordial follicles |
| Abbreviation: GnRHa, gonadotropin-releasing hormone agonists | ||
| Procedure . | Male . | Female . |
|---|---|---|
| Ligand-receptor mediated | GnRHa | GnRHa, steroids |
| Inhibition of apoptosis | - | Bax |
| Surgical | - | Ovarian transposition |
| Cryopreservation | Sperm, spermatogonia | Embryos, oocytes, primordial follicles |
| Abbreviation: GnRHa, gonadotropin-releasing hormone agonists | ||